A detailed history of Saturn V Capital Management LLC transactions in Merus N.V. stock. As of the latest transaction made, Saturn V Capital Management LLC holds 164,773 shares of MRUS stock, worth $8.98 Million. This represents 3.68% of its overall portfolio holdings.

Number of Shares
164,773
Previous 376,629 56.25%
Holding current value
$8.98 Million
Previous $17 Billion 42.51%
% of portfolio
3.68%
Previous 6.8%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$39.81 - $60.2 $8.43 Million - $12.8 Million
-211,856 Reduced 56.25%
164,773 $9.75 Billion
Q1 2024

May 15, 2024

SELL
$28.03 - $51.82 $356,093 - $658,321
-12,704 Reduced 3.26%
376,629 $17 Billion
Q4 2023

Feb 14, 2024

BUY
$20.06 - $28.66 $7.01 Million - $10 Million
349,267 Added 871.73%
389,333 $10.7 Billion
Q3 2023

Nov 14, 2023

BUY
$20.13 - $27.29 $806,528 - $1.09 Million
40,066 New
40,066 $945 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.5B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.